Although there is no cure yet, schizophrenia is highly treatable, with early detection and ongoing treatment.

Classes are held every Tuesdays at 7 PM, from October 23 to November 27, 2007. They were overseen by Hani Iskandar, MD, Clinical Chief at Psychiatric Intensive Care Unit and Coordinator in Undergraduate Medical Education at Douglas I

The laboratory directed by Bruno Giros, PhD, studies the molecular networks of dopamine and glutamate receptors and transporters, two neurotransmitters that play a key role in schizophrenia.

Directed by Gillian O'Driscoll, PhD, the lab focuses on the neural basis of what are considered "behavioural markers of risk" for schizophrenia.

The lab team studies the effect of prenatal stress on childhood development and the various risk factors associated with schizophrenia.  

Research in schizophrenia > Martin Lepage's lab conducts research on the neural circuitry behind memory dysfunctions, lack of insight and social anxiety.

Directed by Natalie Grizenko, MD, and Ridha Joober, MD, PhD, the laboratory studies the genetic and pharmacogenetic aspects of psychiatric disorders such as schizophrenia, ADHD and eating disorders.

Directed by Sylvain Williams, PhD, the lab is interested in two brain structures – the hippocampus and the septum – which interact closely in order to generate critical aspects of learning and memory.

The laboratory of Patricia Boksa, PhD, has shown that birth complications can change the way in which the brain’s dopamine systems respond to stress in adulthood.

Directed by J. Bruno Debruille, MD, PhD, the laboratory attempts to discover the neurocognitive mechanisms of psychotic symptoms of schizophrenia, such as delusions, hallucinations, and alienation.